Assessing Renal Function in Patients With an Antibiotic Laden Spacer
- Conditions
- Infected Total Hip or Knee Arthroplasty
- Registration Number
- NCT01683734
- Lead Sponsor
- Central DuPage Hospital
- Brief Summary
The purpose of this study is to monitor the renal function of patients who have an antibiotic laden spacer in place to treat an infected hip or knee arthroplasty.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
- All patients undergoing a hip or knee resection arthroplasty by the primary investigator
- Ages 18+
- Ability to adhere to follow up schedule
Exclusion Criteria
- Unable to give informed consent
- Age <18
- Previous history of infected Total Knee Arthroplasty or Total Hip Arthroplasty
- History of renal failure or impaired renal function
- Allergies to aminoglycosides or Vancomycin
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Development of acute renal insufficiency or acute renal failure measured by changes in laboratory values assessing renal function subjects will be followed during the time the antibiotic spacer is in place which is approximately 8 weeks
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link antibiotic laden spacers to nephrotoxicity in infected arthroplasty patients?
How does the nephrotoxicity of antibiotic laden spacers compare to standard-of-care treatments for hip/knee infections?
Which biomarkers can predict renal function decline in patients with antibiotic laden spacers for joint infections?
What are the most effective management strategies for nephrotoxicity caused by antibiotic laden spacers in orthopedic surgery?
Are there alternative antibiotic combinations or delivery methods that reduce nephrotoxicity in infected total hip/knee arthroplasty?
Trial Locations
- Locations (2)
RUSH University Medical Center
🇺🇸Chicago, Illinois, United States
Central DuPage Hospital
🇺🇸Winfield, Illinois, United States
RUSH University Medical Center🇺🇸Chicago, Illinois, United States
